I kliniske studier op til 12 uger af både perifere og centrale neuropatiske smerter ses en reduktion af smerter efter 1 uge, og denne reduktion opretholdes gennem hele behandlingsperioden.
In clinical trials up to 12 weeks for both peripheral and central neuropathic pain, a reduction in pain was seen by week 1 and was maintained throughout the treatment period.